NCT01264224

PAC-14028 in Healthy Male Volunteers

A Dose-block Randomized, Double-blind, Placebo-controlled Single/Multiple Dosing, Dose-escalation Phase I Clinical Trial to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of PAC-14028 After Oral Administration in Healthy Male Volunteers.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Amorepacific Corporation · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

1. Primary Objective: * To evaluate safety and tolerability of single and multiple oral dosing of PAC-14028 in healthy male volunteers. 2. Secondary Objective: * To evaluate pharmacokinetics and pharmacodynamics of single and multiple oral dosing of PAC-14028 in healthy male volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	PAC-14028	tablets, oral administration, single/multiple dosing, dose escalation

Timeline

• Start date: 2010-12-01
• Primary completion: 2012-06-01
• First posted: 2010-12-21
• Last updated: 2014-01-22

Locations

1 site across 1 country: South Korea